Action of dexmedetomidine on the substantia gelatinosa neurons of the rat spinal cord
暂无分享,去创建一个
[1] J. Sirviö,et al. Pharmacological characterization and CNS effects of a novel highly selective α2C‐adrenoceptor antagonist JP‐1302 , 2007, British journal of pharmacology.
[2] A. But,et al. The effects of pre‐operative dexmedetomidine infusion on hemodynamics in patients with pulmonary hypertension undergoing mitral valve replacement surgery , 2006, Acta anaesthesiologica Scandinavica.
[3] E. Kumamoto,et al. Tramadol produces outward currents by activating μ‐opioid receptors in adult rat substantia gelatinosa neurones , 2005, British journal of pharmacology.
[4] R. Luján,et al. Spinal G-Protein-Gated Potassium Channels Contribute in a Dose-Dependent Manner to the Analgesic Effect of μ- and δ- But Not κ-Opioids , 2005, The Journal of Neuroscience.
[5] E. Kumamoto,et al. Actions of noradrenaline on substantia gelatinosa neurones in the rat spinal cord revealed by in vivo patch recording , 2004, The Journal of physiology.
[6] Hiroshi Baba,et al. Peripheral nerve injury alters excitatory synaptic transmission in lamina II of the rat dorsal horn , 2003, The Journal of physiology.
[7] E. Kumamoto,et al. Alpha 2 adrenoceptor-mediated presynaptic inhibition of primary afferent glutamatergic transmission in rat substantia gelatinosa neurons. , 2003, Anesthesiology.
[8] L. Jan,et al. Contribution of GIRK2-mediated postsynaptic signaling to opiate and α2-adrenergic analgesia and analgesic sex differences , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] D. Maxwell,et al. An investigation of neurones that possess the α2C-adrenergic receptor in the rat dorsal horn , 2002, Neuroscience.
[10] De-Pei Li,et al. Inhibition of Glutamatergic Synaptic Input to Spinal Lamina IIo Neurons by Presynaptic α2-Adrenergic Receptors , 2002 .
[11] R. Venn,et al. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. , 2001, British journal of anaesthesia.
[12] Ping Li,et al. Cholinergic, noradrenergic, and serotonergic inhibition of fast synaptic transmission in spinal lumbar dorsal horn of rat , 2001, Brain Research Bulletin.
[13] J. Sandkühler,et al. Differential actions of spinal analgesics on mono-versus polysynaptic Aδ-fibre-evoked field potentials in superficial spinal dorsal horn in vitro , 2000, Pain.
[14] M. Yoshimura,et al. Norepinephrine Facilitates Inhibitory Transmission in Substantia Gelatinosa of Adult Rat Spinal Cord (Part 1): Effects on Axon Terminals of GABAergic and Glycinergic Neurons , 2000, Anesthesiology.
[15] S. Dohi,et al. Antinociception by Epidural and Systemic &agr;2-Adrenoceptor Agonists and Their Binding Affinity in Rat Spinal Cord and Brain , 2000, Anesthesia and analgesia.
[16] T. Hökfelt,et al. Distribution of alpha2-adrenoceptor mRNAs in the rat lumbar spinal cord in normal and axotomized rats. , 1999, Neuroreport.
[17] I. Rampil,et al. Ethanol directly depresses AMPA and NMDA glutamate currents in spinal cord motor neurons independent of actions on GABAA or glycine receptors. , 1999, The Journal of pharmacology and experimental therapeutics.
[18] T. Hökfelt,et al. Differential Distribution of α2A and α2C Adrenergic Receptor Immunoreactivity in the Rat Spinal Cord , 1998, The Journal of Neuroscience.
[19] R. H. Evans,et al. Depression of NMDA receptor‐mediated synaptic transmission by four α2 adrenoceptor agonists on the in vitro rat spinal cord preparation , 1998, British journal of pharmacology.
[20] T. Miyazaki,et al. Presynaptic inhibition by noradrenaline of the EPSC evoked in neonatal rat sympathetic preganglionic neurons , 1998, Brain Research.
[21] R. Eglen,et al. Ligand Efficacy and Potency at Recombinant α2 Adrenergic Receptors: Agonist-Mediated [35s]gtpγs Binding , 1998 .
[22] M. Scheinin,et al. Gene targeting — homing in on α2-adrenoceptor-subtype function , 1997 .
[23] H. Higashi,et al. A novel slow excitatory postsynaptic current in substantia gelatinosa neurons of the rat spinal cord in vitro , 1996, Neuroscience.
[24] T. Guo,et al. Dexmedetomidine Injection into the Locus Ceruleus Produces Antinociception , 1996, Anesthesiology.
[25] J. Eisenach,et al. Epidural clonidine analgesia for intractable cancer pain , 1995, Pain.
[26] T. Nishikawa,et al. Thoracic epidural clonidine and morphine for postoperative pain relief , 1995, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[27] K. Filos,et al. Hemodynamic and Analgesic Profile after Intrathecal Clonidine in Humans: A Dose-Response Study , 1994, Anesthesiology.
[28] S. Shafer,et al. Pharmacokinetics and Pharmacodynamics of Intraspinal Dexmedetomidine in Sheep , 1994, Anesthesiology.
[29] P. Molinoff,et al. International Union of Pharmacology nomenclature of adrenoceptors. , 1994, Pharmacological reviews.
[30] M. Scheinin,et al. Use of recombinant human α2-adrenoceptors to characterize subtype selectivity of antagonist binding , 1993 .
[31] M. Yoshimura,et al. Blind patch-clamp recordings from substantia gelatinosa neurons in adult rat spinal cord slices: Pharmacological properties of synaptic currents , 1993, Neuroscience.
[32] T. Hökfelt,et al. Distributions of mRNAs for alpha‐2 adrenergic receptor subtypes in rat brain: An in situ hybridization study , 1993, The Journal of comparative neurology.
[33] K. Korttila,et al. Dexmedetomidine Infusion for Maintenance of Anesthesia in Patients Undergoing Abdominal Hysterectomy , 1992, Anesthesia and analgesia.
[34] T. Yaksh,et al. Relative efficacy of spinal alpha-2 agonists, dexmedetomidine, clonidine and ST-91, determined in vivo by using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible antagonist. , 1991, The Journal of pharmacology and experimental therapeutics.
[35] J. Savola,et al. Central alpha 2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidine. , 1991, European journal of pharmacology.
[36] T. Yaksh,et al. Antinociceptive properties of intrathecal dexmedetomidine in rats. , 1991, European journal of pharmacology.
[37] T. Jessell,et al. Primary afferent-evoked synaptic responses and slow potential generation in rat substantia gelatinosa neurons in vitro. , 1989, Journal of neurophysiology.
[38] M. Maze,et al. Dexmedetomidine Diminishes Halothane Anesthetic Requirements in Rats Through a Postsynaptic Alpha2 Adrenergic Receptor , 1988, Anesthesiology.
[39] D. Bylund. Sub types of α2-adrenoceptors: Pharmacological and molecular biological evidence converg , 1988 .
[40] J. Savola,et al. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. , 1988, European journal of pharmacology.
[41] M. Maze,et al. Clonidine reduces halothane MAC in rats. , 1987, Anesthesiology.
[42] P. Rehak,et al. PREOPERATIVE SILENT MYOCARDIAL ISCHEMIA IN PATIENTS WITH UNSTABLE ANGINA , 1987 .
[43] L. Quintin,et al. Anesthesia and Hypertension: The Effect of Clonidine on Perioperative Hemodynamics and Isoflurane Requirements , 1987, Anesthesiology.
[44] H. Ruskoaho,et al. EVIDENCE FOR MEDETOMIDINE AS A SELECTIVE AND POTENT AGONIST α2‐ADRENORECEPTORS , 1986 .
[45] P. Duke,et al. Effects of Clonidine on Narcotic Requirements and Hemodynamic Response during Induction of Fentanyl Anesthesia and Endotracheal Intubation , 1986, Anesthesiology.
[46] T. Yaksh. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing , 1985, Pharmacology Biochemistry and Behavior.
[47] E. Perl,et al. Excitation of marginal and substantia gelatinosa neurons in the primate spinal cord: Indications of their place in dorsal horn functional organization , 1978, The Journal of comparative neurology.
[48] R. Luján,et al. Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[49] D. Maxwell,et al. An investigation of neurones that possess the alpha 2C-adrenergic receptor in the rat dorsal horn. , 2002, Neuroscience.
[50] De-Pei Li,et al. Inhibition of glutamatergic synaptic input to spinal lamina II(o) neurons by presynaptic alpha(2)-adrenergic receptors. , 2002, Journal of neurophysiology.
[51] L. Stone,et al. alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. , 2002, The Journal of pharmacology and experimental therapeutics.
[52] T. Hökfelt,et al. Differential distribution of alpha2A and alpha2C adrenergic receptor immunoreactivity in the rat spinal cord. , 1998, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[53] R. Eglen,et al. Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding. , 1998, Biochemical pharmacology.
[54] M. Scheinin,et al. Gene targeting--homing in on alpha 2-adrenoceptor-subtype function. , 1997, Trends in pharmacological sciences.
[55] J. Eisenach,et al. Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group. , 1995, Pain.
[56] M. Savasta,et al. Normal distribution of alpha 2‐adrenoceptors in the rat spinal cord and its modification after noradrenergic denervation: A quantitative autoradiographic study , 1994, Journal of neuroscience research.
[57] M. Scheinin,et al. Use of recombinant human alpha 2-adrenoceptors to characterize subtype selectively of antagonist binding. , 1993, European journal of pharmacology.
[58] M. Savasta,et al. Normal distribution of alpha‐1‐adrenoceptors in the rat spinal cord and its modification after noradrenergic denervation: A quantitative autoradiographic study , 1993, Journal of neuroscience research.
[59] D. Bylund. Subtypes of alpha 2-adrenoceptors: pharmacological and molecular biological evidence converge. , 1988, Trends in pharmacological sciences.
[60] H. Ruskoaho,et al. Evidence for medetomidine as a selective and potent agonist at alpha 2-adrenoreceptors. , 1986, Journal of autonomic pharmacology.